Page 6 - Edwards SAPIEN 3 Ultra Implanter Brochure
P. 6

Engineered for your patient's long-term future
Percentage of patients experiencing paravalvular leak at 30 Days2
 ≥ Moderate Mild 100
None/Trace
    12.9
  87.1
 50
0
Edwards SAPIEN 3 Ultra valve features uniform sealing designed to minimize PVL.
 30 Days (N=70)
30-Day findings were Core Lab adjudicated.
SAPIEN 3 Ultra valve Study
30-day findings were core lab adjudicated.
 Percent of patients
 




















































































   4   5   6   7   8